Bioanalytical method validation process includes several procedures, which depict that a particular method that is applied for quantitative measurement of the analytes in a given biological matrix like blood, plasma, serum, or urine, is completely reliable and reproducible for use as intended. It is necessary to employ properly-characterized and fully validated bio-analytical mechanisms to yield reliable results which can be interpreted satisfactorily.
Join expert speaker Edward F. O’Connor, PhD in a live webinar to gain better understanding of similarities and differences in the validation of LC, ligand binding, and cell based and other instrumental assessment approaches.
Who should attend
The following personnel in bio-analytical laboratories
At the Q&A session following the live event, ask a question and get advice unique to your situation, directly from our expert speaker.
- Charles H. Paul,
- Robert J. Russell,
- Greg Sperla and Anthony J. Cortez,
- Jeff Kasoff, RAC, CMQ/OE, LBB
- Danielle DeLucy, MS
- Norma Skolnik,
Edward F. O’Connor,Ph.D. has over 26 years of experience in GLP, GMP and GCP Analysis. He also has dealt extensively with GCMS (FID, ECD, NPD), LC (MS, UV, FL, LSD, CL, COUL, CON), Plate Based Assays ELISA (UV, COL, CL, FL), MSD, Radiometric static and column, In Situ Hybridization of nucleotides, Cell based assays EC50. He also holds mastery of Compliance and Validation Issues. Edward has Directed, Supervised...
More Events By The Speaker